Renishaw completes clinical trial extension study of neuroinfuse drug delivery system to treat Parkinson’s disease

Renishaw Completes Clinical Trial Extension Study of Neuroinfuse Drug Delivery System to Treat Parkinson’s Disease

Global engineering technologies company, Renishaw, has concluded the extension component of its phase 1-2 clinical study, carried out jointly with pharmaceuticals expert Herantis Pharma, which investigated the safety and performance of its neuroinfuse drug delivery device and cerebral dopamine neurotrophic factor (CDNF), as a treatment for Parkinson’s disease.

AK Medical invests in eight GE Arcam EBM 3D printers for orthopedic implants

AK Medical Invests in Eight GE Arcam EBM 3D Printers for Orthopedic Implants

China-based orthopedic implant manufacturer AK Medical has added eight GE Arcam EBM Q10plus 3D printers to its fleet, citing a rising demand for implants across the country. The company has been using EBM (Electron Beam Melting) technology since 2009, working closely with a range of clinical and R&D experts to standardize and certify additively manufactured medical devices in China. Moving forward, AK has stated that it will focus its efforts on 3D printing while expanding beyond just additively manufactured bone joints.